We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04489888
Brief Title: A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)
First Submitted : July 27, 2020
First Submitted that Met QC Criteria : July 27, 2020
First Posted : July 28, 2020
Last Update Submitted that Met QC Criteria : March 27, 2023
Last Update Posted : March 29, 2023